← Eichor
Study identifier: NCT06299514 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

RAFT - Pace &Ablate

Condition: Atrial Fibrillation · Heart Failure · Pacemaker  ·  Sponsor: Habib Khan

PhaseNA
Planned participants600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Atrial fibrillation (AF) is an irregular heartbeat that can cause symptoms of skipped beats, shortness of breath, stroke, or in some cases fluid in the lungs or legs. Treating AF is mostly to do with slowing the heart rate down so that the heart can get a chance to regain some energy. In some cases, slowing the heart rate is not easy to achieve as some patients find it difficult to tolerate medications and suffer side effects from these treatments. In these instances, there might be a possibility to permanently control the heart rate by implanting a pacemaker in the heart and intentionally damaging a regulatory region of the heart called the atrioventricular (AV) node. Damaging the AV node by a procedure called ablation results in the AF not being able to influence the bottom chambers (the ventricles) resulting in a slow rhythm. Therefore, if a pacemaker is implanted then the heart rate can be completely regulated by the pacemaker. A complex pacemaker that stimulates both the right and left ventricles simultaneously (BiVP) has been used for the last decade prior to AV node ablation. More recently, a technique has been designed to reduce the number of leads in the heart, reduce procedure time and have a similar effect on the heart called Conduction System Pacing (CSP). There is not enough existing evidence to show that a pace and ablate strategy is superior to optimal medical therapy. We intend to compare the efficacy of CSP with AV node ablation to optimal medical therapy fo…

This description comes directly from the study's public registry record.

Talk to the study team

Habib R Khan, MBBS, PhD  ·  519-6633746  ·  habib.khan@lhsc.on.ca

Kelli Tyndall  ·  519-685-8500  ·  Kelli.Tyndall@lhsc.on.ca

Always discuss trial participation with your own doctor first.

Locations (12)

Victoria Cardiac Arrhythmia TrialsVictoria, British Columbia, CanadaRecruiting
Nova Scotia Health AuthorityHalifax, Nova Scotia, CanadaRecruiting
Hamilton Health Sciences CorporationHamilton, Ontario, CanadaRecruiting
Waterloo Wellington Cardiovascular Research InstituteKitchener, Ontario, CanadaRecruiting
London Health Sciences Centre - University HospitalLondon, Ontario, CanadaRecruiting
Southlake Regional Health CentreNewmarket, Ontario, CanadaRecruiting
Ottawa Heart Institute Research CorporationOttawa, Ontario, CanadaRecruiting
Sunnybrook Health Sciences CentreToronto, Ontario, CanadaRecruiting
Centre Hospitalier de L'Université de Montréal (CHUM)Montreal, Quebec, CanadaRecruiting
Montreal Heart InstituteMontreal, Quebec, CanadaRecruiting
Institut universitaire de cardiologie et de pneumologie Québec - Université Laval (IUCPQ-ULaval)Québec, Quebec, CanadaRecruiting
Hôpital FleurimontSherbrooke, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06299514